Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer
出版年份 2021 全文链接
标题
Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer
作者
关键词
-
出版物
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-04
DOI
10.1007/s00432-020-03477-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features
- (2020) Zelin Ma et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47−mediated ‘don’t-eat-me’ signal
- (2019) Mingen Liu et al. NATURE IMMUNOLOGY
- Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy
- (2019) Meike E. W. Logtenberg et al. NATURE MEDICINE
- Determining cell type abundance and expression from bulk tissues with digital cytometry
- (2019) Aaron M. Newman et al. NATURE BIOTECHNOLOGY
- Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
- (2019) Andreas Kahlmeyer et al. Journal of Clinical Medicine
- Genomic and immune profiling of pre-invasive lung adenocarcinoma
- (2019) Haiquan Chen et al. Nature Communications
- Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
- (2019) Xuyao Zhang et al. Journal for ImmunoTherapy of Cancer
- A Glutamine-Rich Carrier Efficiently Delivers Anti-CD47 siRNA Driven by a “Glutamine Trap” To Inhibit Lung Cancer Cell Growth
- (2018) Jiamin Wu et al. MOLECULAR PHARMACEUTICS
- Prognostic significance of CD47 in human malignancies: a systematic review and meta-analysis
- (2018) Hui-Jun Zhao et al. Translational Cancer Research
- Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer
- (2018) Jyothi Thyagabhavan Mony et al. Frontiers in Immunology
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
- (2017) Liang Liu et al. Frontiers in Immunology
- CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
- (2016) Hui Zhao et al. Scientific Reports
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy
- (2014) J. L. Lindner et al. ANNALS OF ONCOLOGY
- Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma
- (2014) Terence Kin-Wah Lee et al. HEPATOLOGY
- Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion
- (2014) Emelie Karnevi et al. IMMUNOLOGY AND CELL BIOLOGY
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Biomarker Discovery in Non-Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
- (2012) J. Botling et al. CLINICAL CANCER RESEARCH
- CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma
- (2012) SHIGEMASA SUZUKI et al. ONCOLOGY REPORTS
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
- (2012) Qiong-wen Zhang et al. PLoS One
- Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma
- (2012) B. Edris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
- (2011) M. P. Chao et al. BLOOD
- Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction
- (2010) Bernhard Mlecnik et al. BMC GENOMICS
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Correlated Expression of CD47 and SIRPA in Bone Marrow and in Peripheral Blood Predicts Recurrence in Breast Cancer Patients
- (2010) M. Nagahara et al. CLINICAL CANCER RESEARCH
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
- (2009) K. S. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation